-
Innovation Ranking
NewInnovation Ranking – Perrigo Co Plc
Perrigo Co Plc (Perrigo) is an over-the-counter consumer goods and specialty pharmaceutical company. It develops, manufactures and distributes over-the-counter products, generic, specialty pharmaceutical company, nutritional products, and infant formulas and foods. The company’s major products include analgesics, gastrointestinal, personal care and derma therapeutics, clobetasol spray, clindamycin foam, mupirocin ointment, Ketoconazole, halobetasol ointment and cream and permethrin cream. It markets products through wholesalers, retail drugs, supermarket and mass merchandise chains and direct sales representatives. The company has operational presence in various...
-
Company Insights
Innovation and Patenting activity of Perrigo Co Plc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Perrigo Co Plc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Thematic Analysis
Internet of Things (IoT) in Healthcare – Thematic Intelligence
Internet of Things (IoT) in Healthcare Thematic Report Overview Digital transformation has been a steady trend within healthcare for several years. IoT-enabled technologies such as electronic health records, remote patient monitoring, and wearable devices streamline the patient experience and give patients greater agency in their care. The COVID-19 pandemic made the need for IoT more pressing as healthcare providers were forced to enact social distancing policies and cope with staff shortages and patient backlogs while mandated to provide the same...
-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...
-
Track & Monitor
Innovation in pharma: amyloid precursor targeted therapies
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the pharma industry’s amyloid precursor targeted therapies segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Sector Analysis
Western Europe Consumer Health Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Western Europe Consumer Health Market Overview The Western Europe Consumer Health market size was $46.4 billion in 2022. The market is likely to grow at a CAGR of more than 2% during 2022-2027. Based on the relative performance of countries on multiple metrics, the UK, Switzerland, the Netherlands, and Sweden were shortlisted as high-potential countries, primarily due to their large consumer health industry sizes. Western Europe Consumer Health Market Outlook 2022-2027 ($ Billion) Buy the Full Report for More Insights...
-
Product Insights
Perrigo – Holland Charter Township Manufacturing Facility – Michigan
Equip yourself with the essential tools needed to make informed and profitable decisions with our Perrigo - Holland Charter Township Manufacturing Facility - Michigan report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Perrigo – Infant Formula Production Plant Expansion – Wisconsin
Equip yourself with the essential tools needed to make informed and profitable decisions with our Perrigo - Infant Formula Production Plant Expansion - Wisconsin report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Company Profile
Perrigo Co Plc – Company Profile
Perrigo Co Plc (Perrigo) is an over-the-counter consumer goods and specialty pharmaceutical company. It develops, manufactures and distributes over-the-counter products, generic, specialty pharmaceutical company, nutritional products, and infant formulas and foods. The company’s major products include analgesics, gastrointestinal, personal care and derma therapeutics, clobetasol spray, clindamycin foam, mupirocin ointment, Ketoconazole, halobetasol ointment and cream and permethrin cream. It markets products through wholesalers, retail drugs, supermarket and mass merchandise chains and direct sales representatives. The company has operational presence in various...
Add to Basket -
Sector Analysis
Eastern Europe Consumer Health Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Eastern Europe Consumer Health Market Report Overview The Eastern Europe consumer health market size was valued at $10.8 billion in 2022. The market is expected to achieve a CAGR of more than 1% during 2022-2027. Based on the relative performance of countries on multiple metrics, Romania, Hungary, Slovakia, and Poland were shortlisted as high-potential countries, primarily owing to their large consumer health industry sizes. chemists/pharmacies was the leading distribution channel in the Eastern Europe consumer health industry in 2022. Eastern...